Nurse Practitioner Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Serena Brown

Nurse Practitioner, Primary Care Fort Myers, FL Nurse Practitioner

NPI 1083124648 CMS profile 10729456

13778 Plantation Rd, Fort Myers, FL 33912

Open in the dashboard

General payments

$2,645

12 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Serena Brown of Fort Myers, FL is reported in the CMS Open Payments database as having received $2,645 across 12 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Nurse Practitioner, Primary Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $137 1
2024 General $2,256 10
2023 General $251 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Serena Brown
  • Nurse Practitioner, Primary Care median
  • Middle half of Nurse Practitioner, Primary Care
  • National median

In program year 2025, general payments to Serena Brown were reported at $137. Among 4,814 Nurse Practitioner, Primary Care profiles paid that year, the median was $169 and the middle half received between $51 and $499.

Show as a table
Year Serena Brown Nurse Practitioner, Primary Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $137 $39–$445 $132
2022 $0 $139 $44–$421 $149
2023 $251 $163 $53–$481 $160
2024 $2,256 $176 $54–$511 $164
2025 $137 $169 $51–$499 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Solventum Corporation $1,979 8 payments
  2. Aroa Biosurgery Incorporated $506 2 payments
  3. Integra LifeSciences Corporation $137 1 payment
  4. Abiomed $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Travel and Lodging $1,601 3 payments
  2. Food and Beverage $1,044 9 payments
Products named General payments · program years 2023–2025
  1. PREVENA $1,979 8 payments
  2. V.A.C. VERAFLO CLEANSE CHOICE $857 2 payments
  3. V.A.C. VERAFLO $732 1 payment
  4. Bair Hugger $732 1 payment
  5. PREVENA RESTOR ARTHROFORM $732 1 payment
  6. Integra Recon-Skin And Wound $137 1 payment
  7. Integra Recon-Skin And Wound $137 1 payment
  8. Integra Recon-Skin And Wound $137 1 payment
  9. INTEGRA DERMAL REGENERATION TEMPLATE $137 1 payment
  10. PRIMATRIX $137 1 payment
  11. Other $22 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$12,926

Medicare's payments for the services billed

Medicare patients

104

Average age 77

Services billed

180

44 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 65%
Diabetes 63%
Heart failure 61%
Arthritis 61%
Atrial fibrillation 53%
Chronic kidney disease 50%
COPD 44%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

12 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record